Stocks To Buy Now

Blog


Oakridge Global Energy Solution, Inc. (OGES) Mentioned in Press Conference with Florida Governor

“New To The Street” (NTTS), a television show that profiles public companies and reports on financial news, this morning highlighted its recent taping of Florida’s Governor Rick Scott’s press conference at the headquarters of Oakridge Global Energy Solution. The interview is the second interview in the series with Oakridge Global Energy CEO Steve Barber.

Governor Scott spoke about the importance of U.S. manufacturing, and how Oakridge Global fits into the applauded slogan, “Made in America.” As an integrated “made in the USA” energy storage solutions company that uses cutting-edge technology to focus on developing advanced, high-quality cells, batteries and power systems for consumer, government, industrial and military applications, Oakridge Global Energy is the recipient of aid initiatives totaling approximately $33 million from the State of Florida, County, City and other public sources.

The company’s strategy is to simultaneously deliver innovation and build an industrial scale platform that includes multiple lithium ion technologies and form factors that are optimized to address three target markets: stationary and grid storage; motive applications including fleet vehicles, EV and HEV; and specialty applications including military, aerospace, marine, industrial, scientific and telecom backup.

Oakridge recently initiated production of its ProSeries line of heavy duty battery systems for task-oriented vehicles such as golf cars, maintenance vehicles, forklifts, off road vehicles and other similar applications.

For more information visit www.oakg.net

Let us hear your thoughts: Oakridge Global Energy Solutions, Inc. Message Board

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape

May 9, 2025

A Market Demanding Safer Opioid Solutions The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers […]

Rotate your device 90° to view site.